CIARDULLO STEFANO

Ciardullo, S., Mantovani, A. (2024). Resmetirom for the treatment of nonalcoholic steatohepatitis: Evaluating the robustness of available evidence. DIGESTIVE AND LIVER DISEASE [10.1016/j.dld.2024.03.009]. Detail

Ciardullo, S., Morabito, G., Rea, F., Savaré, L., Perseghin, G., Corrao, G. (2024). Time trends in liver-related mortality in people with and without diabetes: Results from a population based study. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM [10.1210/clinem/dgae182]. Detail

Ciardullo, S., Mantovani, A., Morieri, M., Muraca, E., Invernizzi, P., Perseghin, G. (2024). Impact of MASLD and MetALD on clinical outcomes: A meta-analysis of preliminary evidence. LIVER INTERNATIONAL [10.1111/liv.15939]. Detail

Hassoun, S., Bruckmann, C., Ciardullo, S., Perseghin, G., Marra, F., Curto, A., et al. (2024). NAIF: A novel artificial intelligence-based tool for accurate diagnosis of stage F3/F4 liver fibrosis in the general adult population, validated with three external datasets. INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 185(May 2024) [10.1016/j.ijmedinf.2024.105373]. Detail

Ciardullo, S., Savaré, L., Rea, F., Perseghin, G., Corrao, G. (2024). Adherence to GLP1-RA and SGLT2-I affects clinical outcomes and costs in patients with type 2 diabetes. DIABETES/METABOLISM RESEARCH AND REVIEWS, 40(4 (May 2024)) [10.1002/dmrr.3791]. Detail